New centre of excellence aims to drive digital innovation in medicines regulation
Posted:
A new £1 million research initiative aims to transform medicines regulation by accelerating the adoption of digital technologies, including artificial intelligence (AI), in drug development and manufacturing.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…